Please login to the form below
Cures Act
This page shows the latest Cures Act news and features for those working in and with pharma, biotech and healthcare.
Signant Health joins the Association of Clinical Research Organizations
st. Century Cures Act and EU Clinical Trial Regulation. Signant Health is the 13.
Latest news
-
ACT immunotherapy cures terminal breast cancer patient
The new approach - a modified version of a technique known as adoptive cell transfer (ACT) - is being developed by researchers at the National Cancer Institute in the US, and involves sequencing ... ACT has been shown to be effective in treating tumours
-
Trump talks pricing and manufacturing with pharma
In particular, there is concern that the orders could effectively stop the 21st Century Cures Act - one of the last actions of the Obama administration and widely welcomed by industry - in
-
Bayer helps bankroll new stem cell company BlueRock
The birth of the new company also comes at an opportune time with the passage in the US of the 21st Century Cures Act, which promises to introduce a truncated registration
-
After Senate vote, Cures Act is en route to Obama for signature
law. The US Senate voted 94 to 5 to approve the 21st Century Cures Act, a wide-ranging and controversial bill that will shake up the operations of the FDA and ... The Biotechnology Innovation Organization (BIO), which represents biotech companies,
-
The fifth estate
Century Cures Act - specifically the goal of making drug and medical devices available faster.
More from news
Approximately 1 fully matching, plus 9 partially matching documents found.
Latest Intelligence
-
The evolution of real-world studies
Regulatory positions. The growing role of RWE in the US is supported by the 21st Century Cures Act, which led the FDA to create a framework for incorporating RWD into regulatory
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
21st Century Cures Act: a commercial perspective on how the new FDA regulation could revolutionise use of RWE and analytics in healthcare
The 21st Century Cures Act was signed into law last December during the Obama administration. ... Enter the 21st Century Cures Act – which opens up credible sources of Real World Evidence (RWE) for commercial use to understand and communicate the value
-
Blue Latitude Health
21st Century Cures Act: a commercial perspective on how the new FDA regulation could revolutionise use of RWE and analytics in healthcare. ... The 21st Century Cures Act has transformed the US drug development landscape.
More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Technical Sales Representative
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- MHRA to introduce new UK clinical trials framework
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- 2023 PM Society Awards – winners announced
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Pfizer and Astellas’ Xtandi shows promise in phase 3 prostate cancer study
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
- VR/AR Applications for Training and Healthcare
PMHub
Six Degrees Medical Consulting
For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
